110823 ⎘
ssRNA viruses negative-sense; Details; Orthomyxoviridae; Influenzavirus A, i.e. influenza A virus Methods of inactivation or attenuation
Sub-classes:INFLUENZA B VIRUS MUTANTS AND USES THEREFOR
#2VIRAL INACTIVATION METHOD, METHOD FOR PRODUCING DRIED AMNION, AND DRIED AMNION
#3Influenza B virus mutants and uses therefor
#4GENERIC ASSAYS FOR DETECTION OF INFLUENZA VIRUSES
#5Influenza vaccines
#6Methods of treating and preventing influenza infections
#7Nanoparticle based vaccine strategy against swine influenza virus
#8NOVEL INFLUENZA VIRUS
#9Live attenuated viral vaccine created by self-attenuation with species-specific artificial MicroRNA
#10Composite antigenic sequences and vaccines
#11Influenza virus reassortment
#12Immunogenic compositions and methods
#13Cell strain having increased virus production ability and production method therefor
#14GENERIC ASSAYS FOR DETECTION OF INFLUENZA VIRUSES
#15Method for preparing virosomes
#16Influenza virus reassortment
#17Attenuated swine influenza vaccines and methods of making and use thereof
#18Influenza vaccines
#19Recombinant influenza vectors with tandem transcription units
#20Immunogenic compositions and methods
#21Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitopes
#22Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#23Modified influenza virus for monitoring and improving vaccine efficiency
#24Modified influenza virus for monitoring and improving vaccine efficiency
#25Reassortant influenza B viruses
#26Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#27GENERIC ASSAY FOR DETECTION OF INFLUENZA VIRUSES
#28Influenza virus
#29Live attenuated influenza virus vaccines comprising microRNA response elements
#30Non-tumorigenic MDCK cell line for propagating viruses
#31Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitopes
#32INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS
#33INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS
#34Recombinant influenza vectors with tandem transcription units
#35Method for Producing the Flu Virus
#36INFLUENZA VACCINES
#37Avian influenza virus live attenuated vaccine and uses thereof
#38Modified influenza virus for monitoring and improving vaccine efficiency
#39Influenza hemagglutinin and neuraminidase variants
#40Influenza hemagglutinin and neuraminidase variants
#41NOVEL METHODS AND INTERFERON DEFICIENT SUBSTRATES FOR THE PROPAGATION OF VIRUSES
#42NOVEL VACCINE COMPOSITION
#43Production of viral vaccine
#44ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS
#45LINEAR EXPRESSION CONSTRUCTS FOR PRODUCTION OF INFLUENZA VIRUS PARTICLES
#46Non-tumorigenic MDCK cell line for propagating viruses
#47Signal for packaging of influenza virus vectors
#48Identifying and predicting influenza variants and uses thereof
#49Virus Vaccines Comprising Envelope-Bound Immunomodulatory Proteins and Methods of Use Thereof
#50Methods for the propagation of modified influenza viruses in embryonated eggs
#51Influenza hemagglutinin and neuraminidase variants
#52Influenza Hemagglutinin And Neuraminidase Variants
#53Influenza hemagglutinin and neuraminidase variants
#54Influenza Virus Vaccine
#55Method for producing the flu virus
#56Immunogenic compositions and methods
#57Method for producing viral vaccines
#58Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#59COMPOUNDS AND METHODS FOR ASSAYING FUSION OF AN INDIVIDUAL, ENVELOPED VIRUS WITH TARGET MEMBRANE
#60NOVEL VACCINE COMPOSITION
#61Attenuated influenza NS1 variants
#62Signal for packaging of influenza virus vector
#63Modified influenza virus for monitoring and improving vaccine efficiency
#64Influenza hemagglutinin and neuraminidase variants
#65Non-tumorigenic MDCK cell line for propagating viruses
#66Recombinant influenza vectors with tandem transcription units
#67Influenza hemagglutinin and neuraminidase variants
#68Influenza hemagglutinin and neuraminidase variants
#69Methods of use of viral vectors to deliver antigen to dendritic cells
#70Viruses comprising mutant ion channel protein
#71Methods and interferon deficient substrates for the propagation of viruses
#72Influenza hemagglutinin and neuraminidase variants